Inven2 is the largest technology transfer office in the Nordic region.
We are responsible for:
- Commercialization of innovations from our owners
- Administration and financial follow up of clinical trials
- Administration of Research fund
Inven2’s goal is to make research benefit society and to contribute to value creation.
Inven2 is owned by the University of Oslo and Oslo University Hospital.
Company Details
- Employees
- 36
- Founded
- -
- Address
- Gaustadalleen 21, Oslo,norge 0349,norway
- Phone
- 47-90 41 71 07
- po****@****en2.com
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- inven2.com
- Keywords
- Tribune Therapeutics.
- HQ
- Oslo, Norge
Inven2 Questions
Inven2's helpline number is 47-90 41 71 07
Inven2's website is inven2.com
Inven2's LinkedIn profile is https://no.linkedin.com/company/inven2
Inven2 has
36 employees.
View email and phone details for 36
employees at Inven2.
Inven2's industry is
Investment Management
Inven2's top competitors are
Oslo Cancer Cluster,
Wild Genomics, Inc.,
Lifearc Ventures,
Tribune Therapeutics,
Healthcap,
Nortrials,
Investinor,
Oslo Cancer Cluster Incubator,
Aleap,
The Life Science Cluster.
Inven2's support email address is post@inven2.com
Inven2's categories are Investment Management
Inven2's founding year is 2010
